LONDON–(BUSINESS WIRE)–#GlobalMycoplasmaTestingMarket–The mycoplasma testing market is poised to grow by USD 445.57 million during 2020-2024, progressing at a CAGR of over 11% during the forecast period.
Worried about Your Business amidst COVID-19 Impact? Get Exclusive Report Talking about Market scenarios, Estimates, Impact of Lockdowns, and Customer Behaviour Get FREE Sample PDF Report in your Inbox within Minutes!
The report on the mycoplasma testing market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis.
The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing focus on the R&D of biopharmaceuticals.
The mycoplasma testing market analysis includes product segment and geography landscape. This study identifies the growing M&A and partnerships between CROs, and pharmaceutical and biotechnology companies as one of the prime reasons driving the mycoplasma testing market growth during the next few years.
This report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.
The mycoplasma testing market covers the following areas:
Mycoplasma Testing Market Sizing
Mycoplasma Testing Market Forecast
Mycoplasma Testing Market Analysis
Companies Mentioned
- Agilent Technologies Inc.
- ATCC
- Becton, Dickinson and Co.
- Charles River Laboratories International Inc.
- F. Hoffmann-La Roche Ltd.
- InvivoGen
- Lonza Group Ltd.
- Merck KGaA
- Norgen Biotek Corp.
-
Thermo Fisher Scientific Inc.
Key Topics Covered:
Executive Summary
Market Landscape
- Market ecosystem
- Value chain analysis
Market Sizing
- Market definition
- Market segment analysis
- Market size 2019
- Market outlook: Forecast for 2019 – 2024
Five Forces Analysis
- Five Force Summary
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
Market Segmentation by Product
- Market segments
- Comparison by Product
- Consumables – Market size and forecast 2019-2024
- Systems – Market size and forecast 2019-2024
- Market opportunity by Product
Market Segmentation by End-user
- Pharmaceutical and biotechnology companies
- CROs
- Academic research institutes
- Cell banks
- Others
Customer Landscape
Geographic Landscape
- Geographic segmentation
- Geographic comparison
- North America – Market size and forecast 2019-2024
- Europe – Market size and forecast 2019-2024
- Asia – Market size and forecast 2019-2024
- ROW – Market size and forecast 2019-2024
- Key leading countries
- Market opportunity by geography
- Volume driver – demand led growth
- Market challenges
- Market trends
Vendor Landscape
- Vendor landscape
- Landscape disruption
- Competitive scenario
Vendor Analysis
- Vendors covered
- Market positioning of vendors
- Agilent Technologies Inc.
- ATCC
- Charles River Laboratories International Inc.
- F. Hoffmann-La Roche Ltd.
- InvivoGen
- Lonza Group Ltd.
- Merck KGaA
- Norgen Biotek Corp.
- Thermo Fisher Scientific Inc.
Appendix
- Scope of the report
- Currency conversion rates for US$
- Research methodology
-
List of abbreviations
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/